Valturna

Active Ingredient(s): Aliskiren + Valsartan
FDA Approved: * September 16, 2009
Pharm Company: * NOVARTIS PHARMS
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Valturna Overview

Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension.[1] While used for high blood pressure, other better studied medications are typically recommended due to concerns of higher side effects and less evidence of benefit.[2] In December 2011, Novartis halted a trial of the drug after discovering increased nonfatal stroke, kidney complications, high blood pota...

Read more Valturna Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aliskiren

Recent Valturna Forums: RSS Feed

metoprold hct

peach color ## what are the side effects of metoprold and what is it used for? ## I am currently using valturna blood pressure medicine dosage 300/325 mg, bp readings in the 110/119 over 60/70 range. Is it safe to take metoprold with this bp medicine

Updated
2 REPLIESSHARERSS

Possible Dosages for this and Related Drugs:

Aliskiren + Valsartan
  • Tablet: 150mg + 160mg, 150mg/160mg, 300mg + 320mg, 300mg/320mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (22 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA